Mon Oct 19, 2009 9:15am EDT A New FDA-Approved Ovarian Cancer Test based on an HDC
Patented Technology HDC`s patented technology played a pivotal role in identifying biomarkers in a recently FDA-approved ovarian cancer test developed by Vermillion, Inc. (VRMLQ.PK). HDC prosecuted a patent infringement action against Vermillion`s predecessor company, Ciphergen Biosystems, Inc., which resulted in a...